𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura

✍ Scribed by F. Ferrara; M. Annunziata; F. Pollio; S. Palmieri; C. Copia; G. Mele; B. Pocali; E. Schiavone

Publisher
Springer
Year
2001
Tongue
English
Weight
40 KB
Volume
81
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of thrombotic thrombocytopenic
Treatment of thrombotic thrombocytopenic purpura: A role for early vincristine administration
✍ Catherine Mazzei; Samuel Pepkowitz; Ellen Klapper; Dennis Goldfinger πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 23 KB πŸ‘ 2 views

Plasma exchange (PE) is considered first-line treatment for thrombotic thrombocytopenic purpura (TTP) to the point that many clinicians regard it as definitive therapy. Studies have reported response rates to PE ranging from 39% to 78%. In our experience, a minority of patients have been cured solel

Rituximab for treatment of refractory/re
Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP)
✍ Afaq Ahmad; Anita Aggarwal; Daya Sharma; Harish P. Dave; Virginia Kinsella; Marg πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 2 views

## Abstract Plasma exchange is the standard treatment for thrombotic thrombocytopenic purpura (TTP). For patients refractory to plasma exchange, treatment options are limited and often unsuccessful. The platelet thrombi that form in acquired TTP are believed to result from the presence of procoagul